Regulatory Affairs
Ground submissions in precedent: designs, endpoints, populations and designations regulators have already accepted.
What this team sees first.
A heatmap shows where development concentrates by phase. Lupus is crowded early; psoriasis is crowded at Phase 3.
Every use case below opens with its signature chart and a recommended set of supporting views, chosen from 91 chart types.
Built for: Regulatory Intelligence Lead, Regulatory Affairs, Regulatory Strategy Lead, Regulatory, Global Regulatory Affairs Lead.
Lupus crowds Phase 1; psoriasis crowds Phase 3
ClinicalTrials.gov API, pulled 16 Oct 2026: active, interventional, industry lead sponsor. A trial listing several conditions or phases counts in each cell.
Ranked by stakes, centrality, reach, frequency and data fit.
Each use case ships with an executive brief, a detailed dossier and a recipe that builds the board in one click.
- RA-01
#10Regulatory intelligence monitoring
Track newly published results that could influence guidance or agency expectations.
For: Regulatory Intelligence LeadDiff / change-highlight viewTimelineKPI / metric snapshot panel - RA-02
#17Regulatory precedent research
Understand what designs, endpoints and populations regulators have accepted historically.
For: Regulatory Affairs / Strategy LeadFeature-by-feature alignment chartKPI / metric snapshot panelHeatmap / matrix - RA-11N
#34Approval-precedent & designation landscape
See the actual approval, label and designation history (orphan, breakthrough, accelerated) in an indication.
For: Regulatory Strategy LeadBullseyeHeatmap / matrixFeature-by-feature alignment chart - RA-03
#39Special protocol assessment preparation
Benchmark a proposed design against those that have successfully supported approvals.
For: Regulatory Strategy LeadFeature-by-feature alignment chartHeatmap / matrixBar / column chart - RA-04
#51Post-marketing commitment tracking
Track competitor post-approval commitments to understand regulatory expectations in your class.
For: Regulatory Intelligence LeadTimelineComposition / share-of-inventory chartBullet chart - RA-05
#58Orphan designation dossier support
Document the full trial landscape in a rare disease to argue treatment options are insufficient.
For: Regulatory AffairsBullseyeHeatmap / matrixFeature-by-feature alignment chart - RA-06
#59Expedited pathway eligibility assessment
Assess whether unmet-need evidence supports Breakthrough, Fast Track or PRIME applications.
For: Regulatory Strategy LeadQuadrant mapKPI / metric snapshot panelHeatmap / matrix - RA-07
#60Label differentiation strategy
Identify clinically meaningful differences that could support a distinct or broader label claim.
For: Regulatory / Labeling Strategy LeadHeatmap / matrixFeature-by-feature alignment chartBar / column chart - RA-08
#61International submission planning
Understand where trials ran under EMA vs. FDA oversight to guide parallel submissions.
For: Global Regulatory Affairs LeadChoropleth mapTimelineHeatmap / matrix - RA-09
#73Risk management plan (RMP) benchmarking
Align your RMP with established regulatory expectations via comparable approved trials.
For: Regulatory / Safety Strategy LeadFeature-by-feature alignment chartTimelineHeatmap / matrix - RA-10
#91Pediatric investigation plan (PIP) mapping
Understand existing pediatric trial experience to inform PIP negotiations.
For: Regulatory Affairs / Pediatric LeadHeatmap / matrixTimelineFeature-by-feature alignment chart
Ask the registry a regulatory question.
AI reads your question into filters; every number comes straight from the ClinicalTrials.gov API. Don't enter personal or confidential information.
Bring one regulatory question to a pilot.
Eight weeks, one programme, success criteria agreed up front.